Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).


TSXV:SBM - Post by User

Comment by lscfaon Jan 24, 2022 2:40pm
152 Views
Post# 34354401

RE:RE:CFO just exercised

RE:RE:CFO just exercised

2,237,934 warrants exercised over and above 750,000 exercised by CEO and CFO => 2.987 mil x $0.16 = $478,069 cash proceeds.     

 

 

Effective Date

Expiry Date

Authorized Shares

Issued

 

18/Jan/2022

 

Unlimited

236,000,000

-67,566

01/Nov/2021

17/Jan/2022

Unlimited

236,067,566

3,022,500

26/Oct/2021

31/Oct/2021

Unlimited

233,045,066

2,418,600

06/Oct/2021

25/Oct/2021

Unlimited

230,626,466

300,000

29/Jul/2021

05/Oct/2021

Unlimited

230,326,466

252,500

30/Jun/2021

28/Jul/2021

Unlimited

230,073,966

180,000

10/May/2021

29/Jun/2021

Unlimited

229,893,966

379,146

17/Mar/2021

09/May/2021

Unlimited

229,514,820

 

 




lscfa wrote: 14 million $0.16 warrants expire Feb 27. ==> $2.24 mil proceeds

 

<< Previous
Bullboard Posts
Next >>